All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

38

Reset

38 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BerobenatidePF-08653944, MET097Phase 319 trials

    Pfizer · Obesity, Overweight and/or Obesity, Overweight

  • GiredestrantRO7197597, GDC-9545Phase 316 trials

    Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer

  • PF-08634404SSGJ-707Phase 312 trials

    Pfizer · Non-Small Cell Lung Cancer, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung (NSCLC)

  • AtirmociclibPF-07220060Phase 39 trials

    Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • RSVpreFRESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, PF-06928316Phase 38 trials

    Pfizer · Respiratory Syncytial Virus (RSV), Lower Respiratory Tract Illness, Adult

  • PG4Phase 35 trials

    Pfizer · Pneumococcal Disease

  • DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization

  • VLA15PF-07307405Phase 34 trials

    Pfizer · Lyme Disease, Lyme Borreliosis

  • CasdatifanAB521Phase 33 trials

    Arcus Biosciences, Inc. · Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC)

  • Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials

    Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate

  • MevrometostatPF-06821497Phase 33 trials

    Pfizer · Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer

  • RSVpreF VaccinePhase 33 trials

    Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)

  • Sigvotatug VedotinSGN-B6A, PF-08046047Phase 33 trials

    Pfizer · Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

  • C.difficile vaccinepreviously studiedPhase 32 trials

    Pfizer · Clostridoides Difficile Associated Disease

  • CMP 001VidutolimodPhase 32 trials

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • ibuzatrelvirPF-07817883Phase 32 trials

    Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection

  • PF-07248144Phase 32 trials

    Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • PF-08046054SGN-PDL1VPhase 32 trials

    Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma

  • su vaccineRZVPhase 32 trials

    GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)

  • PF-06823859Phase 31 trial

    Pfizer · Myositis

  • PF-06838435fidanacogene elaparvovecPhase 31 trial

    Pfizer · Hemophilia B

  • PF04518600Phase 31 trial

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • ponsegromabPhase 31 trial

    Pfizer · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma

  • Prevenar 20Phase 31 trial

    Pfizer · Healthy

  • SasanlimabPF-06801591Phase 31 trial

    Pfizer · Non-muscle Invasive Bladder Cancer

  • UtomilumabPhase 31 trial

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • PF-07104091ovarian, SCLCPhase 22 trials

    Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer

  • MET233Phase 21 trial

    Pfizer · Obesity and Obesity-related Medical Conditions

  • PCV1515-valent pneumococcal conjugate vaccinePhase 21 trial

    Pfizer · Pneumococcal Disease

  • PF-0704091Phase 21 trial

    Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer

  • PF-07264660Phase 21 trial

    Pfizer · Atopic Dermatitis

  • PF-07328948Phase 21 trial

    Pfizer · Heart Failure

  • PF-07868489Phase 21 trial

    Pfizer · Pulmonary Arterial Hypertension

  • PF-07976016Phase 21 trial

    Pfizer · Obesity

  • PF-08049820Phase 21 trial

    Pfizer · Atopic Dermatitis, Eczema, Atopic

  • PF-08154225Phase 21 trial

    Pfizer · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis

  • PF-08653945Phase 21 trial

    Pfizer · Overweight, Obesity, Overweight and/or Obesity

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.